Role of hTERT rs2736100 in pathological scarring

Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family histor...

Full description

Saved in:
Bibliographic Details
Published in:Experimental and therapeutic medicine Vol. 23; no. 4
Main Authors: Ilies, Roxana Flavia, Halmagyi, Salomea-Ruth, Catana, Andreea, Aioanei, Casian Simon, Lukacs, Istvan, Tokes, Reka- Eniko, Rotar, Ioana Cristina, Pop, Ioan Victor
Format: Journal Article
Language:English
Published: Athens Spandidos Publications 01-04-2022
Spandidos Publications UK Ltd
D.A. Spandidos
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/[m.sup.2] was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section. Key words: hTERT, single nucleotide polymorphism, hypertrophic scar, atrophic scar, RT-PCR
AbstractList Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/[m.sup.2] was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section. Key words: hTERT, single nucleotide polymorphism, hypertrophic scar, atrophic scar, RT-PCR
Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase ( hTERT ) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/m 2 was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section.
Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/m2 was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section.
Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has acquired significant attention due to the diverse phenotype of pathological scarring in individuals with a positive personal and family history. Recent studies have identified telomere shortening and decreased hTERT activity in pathological scarring, proposing the rs2736100 variant of human telomerase reverse transcriptase (hTERT) gene as a valuable variant gene candidate. We examined the scarring process in 71 female patients who had undergone Caesarean section and developed hypertrophic and atrophic scars with the objective to investigate the role of single nucleotide polymorphism (SNP) rs2736100 in pathological scarring. Genotyping was performed using RT-PCR and follow-up included the Patient Observer Scar Assessment Scale (POSAS) and SCAR scales. Comparative analysis for mean POSAS value between the check-ups at 3 and 6 months revealed a statistical decreased difference of 1.71 points [95% confidence interval (CI), 0.4-2.89; P=0.01], while SCAR highlighted a decreased difference of 0.670 (95% CI, -0.04-1.38; P=0.055). The C variant allele revealed a borderline statistical value for the risk of developing pathological scarring (OR=1.44; 95% CI, 0.876-1.332: P=0.066). In our study a pre-conceptional body mass index (BMI) >25 kg/[m.sup.2] was statistically associated with pathological scarring. The Fitzpatrick type 4 phototype displayed an increased frequency for the heterozygous genotype in the current study, and it was demonstrated that dark skin tone was associated with abnormal scar formation. Our study investigated the role of hTERT gene variant rs2736100 in hypertrophic and atrophic scarring in a Caucasian population group. We report a borderline statistically significant value for the variant C allele of hTERT SNP for the risk of developing pathological scarring in female patients that had undergone Caesarean section.
ArticleNumber 260
Audience Academic
Author Ilies, Roxana Flavia
Catana, Andreea
Lukacs, Istvan
Tokes, Reka- Eniko
Rotar, Ioana Cristina
Halmagyi, Salomea-Ruth
Pop, Ioan Victor
Aioanei, Casian Simon
AuthorAffiliation 1 Department of Medical Genetics, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
2 Department of Oncogenetics, ‘Ion Chiricuță’ Oncological Institute, 400015 Cluj-Napoca, Romania
3 1st Department of Obstetrics and Gynecology, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
4 1st Clinic of Obstetrics and Gynecology, Emergency County Hospital, 400006 Cluj-Napoca, Romania
AuthorAffiliation_xml – name: 1 Department of Medical Genetics, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
– name: 3 1st Department of Obstetrics and Gynecology, ‘Iuliu Hațieganu’ University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania
– name: 2 Department of Oncogenetics, ‘Ion Chiricuță’ Oncological Institute, 400015 Cluj-Napoca, Romania
– name: 4 1st Clinic of Obstetrics and Gynecology, Emergency County Hospital, 400006 Cluj-Napoca, Romania
Author_xml – sequence: 1
  fullname: Ilies, Roxana Flavia
– sequence: 2
  fullname: Halmagyi, Salomea-Ruth
– sequence: 3
  fullname: Catana, Andreea
– sequence: 4
  fullname: Aioanei, Casian Simon
– sequence: 5
  fullname: Lukacs, Istvan
– sequence: 6
  fullname: Tokes, Reka- Eniko
– sequence: 7
  fullname: Rotar, Ioana Cristina
– sequence: 8
  fullname: Pop, Ioan Victor
BookMark eNptkc1LAzEQxYMoVqtXzwueu04myW72IhTxCwSh1HPIZrNtZHdTk63gf2_UUhCaOSTM_ObxyDsnx4MfLCFXFHImK7yxY58jIOaUUlkckTNaVjijQMXx7g2VpBNyGeM7pCMKKqU4JRMmUFCGxRmBhe9s5ttsvbxfLLMQsWQFBcjckG30uPadXzmjuywaHYIbVhfkpNVdtJe7e0reHu6Xd0-zl9fH57v5y8xwKsZZqznXgJzJGqsWQTYUGceKiSpZN8h5gzLNsWbIaqihMbySBaemNZIlbkpu_3Q327q3jbHDGHSnNsH1Onwpr536PxncWq38p5LpZwpkSeB6JxD8x9bGUb37bRiSZ4UF52UBkLA9tdKdVW5ofRIzvYtGzUuACgWIMlH5ASpVY3tnUiitS_1DCyb4GINt98YpqJ_sVMpO_WSnfrNj3zB-h0k
CitedBy_id crossref_primary_10_1007_s13167_022_00309_x
Cites_doi 10.1007/s00238-011-0661-3
10.3109/14764172.2010.514924
10.1111/j.1600-0846.2008.00327.x
10.2119/molmed.2009.00153
10.1111/ddg.13027_g
10.1111/wrr.12302
10.1007/s00403-009-1014-y
10.1111/bjd.13826
10.1097/01.ta.0000108997.49513.dc
10.1016/j.jisp.2016.10.024
10.1016/j.bjps.2015.11.015
10.3892/etm.2019.7513
10.1186/1471-2350-10-110
10.1097/DAD.0b013e31825ba13f
10.1097/MCO.0b013e32834121b1
10.1186/s12929-018-0422-8
10.1001/archderm.124.6.869
10.1371/journal.pone.0097114
10.1016/j.burns.2005.01.022
10.1016/j.yexcr.2016.05.013
ContentType Journal Article
Copyright COPYRIGHT 2022 Spandidos Publications
Copyright Spandidos Publications UK Ltd. 2022
Copyright © 2020, Spandidos Publications 2020
Copyright_xml – notice: COPYRIGHT 2022 Spandidos Publications
– notice: Copyright Spandidos Publications UK Ltd. 2022
– notice: Copyright © 2020, Spandidos Publications 2020
DBID AAYXX
CITATION
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AN0
BENPR
CCPQU
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOI 10.3892/etm.2022.11186
DatabaseName CrossRef
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
British Nursing Database
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Health & Medical Collection (Alumni Edition)
Nursing & Allied Health Premium
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
British Nursing Index with Full Text
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList

ProQuest One Academic Eastern Edition

DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1792-1015
ExternalDocumentID A700925057
10_3892_etm_2022_11186
GeographicLocations Romania
GeographicLocations_xml – name: Romania
GroupedDBID ---
0R~
3V.
53G
7RV
7X7
8FI
8FJ
AAKDD
AAYXX
ABDBF
ABJNI
ABUWG
ACGFS
ADBBV
AENEX
AFKRA
AHMBA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AN0
BENPR
BKEYQ
BNQBC
BPHCQ
BVXVI
C45
CCPQU
CITATION
EBD
EBS
EJD
ESX
F5P
FYUFA
H13
HMCUK
HUR
HZ~
IAO
IHR
IPNFZ
ITC
NAPCQ
O9-
OK1
OVD
PQQKQ
PROAC
RIG
RPM
TEORI
UKHRP
7XB
8FK
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c415t-fa44a02438b29f208d123429359389c244d280242b323b0b0dc498641cfc83293
IEDL.DBID RPM
ISSN 1792-0981
IngestDate Tue Sep 17 20:46:31 EDT 2024
Thu Oct 10 15:20:40 EDT 2024
Tue Nov 19 21:22:38 EST 2024
Tue Nov 12 23:28:44 EST 2024
Fri Aug 23 03:06:32 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 4
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c415t-fa44a02438b29f208d123429359389c244d280242b323b0b0dc498641cfc83293
Notes Abbreviations: SNP, single nucleotide polymorphism; POSAS, Patient Observer Scar Assessment Scale; RT-PCR, real-time polymerase chain reaction
Contributed equally
OpenAccessLink https://www.spandidos-publications.com/10.3892/etm.2022.11186/download
PMID 35251326
PQID 2644760062
PQPubID 2044959
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8892623
proquest_journals_2644760062
gale_infotracmisc_A700925057
gale_infotracacademiconefile_A700925057
crossref_primary_10_3892_etm_2022_11186
PublicationCentury 2000
PublicationDate 2022-04-01
PublicationDateYYYYMMDD 2022-04-01
PublicationDate_xml – month: 04
  year: 2022
  text: 2022-04-01
  day: 01
PublicationDecade 2020
PublicationPlace Athens
PublicationPlace_xml – name: Athens
PublicationTitle Experimental and therapeutic medicine
PublicationYear 2022
Publisher Spandidos Publications
Spandidos Publications UK Ltd
D.A. Spandidos
Publisher_xml – name: Spandidos Publications
– name: Spandidos Publications UK Ltd
– name: D.A. Spandidos
References Butzelaar (key20220330120639_b19-ETM-0-0-11186) 2016; 69
Deliaert (key20220330120639_b20-ETM-0-0-11186) 2012; 35
De Felice (key20220330120639_b12-ETM-0-0-11186) 2009; 10
Li (key20220330120639_b15-ETM-0-0-11186) 2016; 345
Leão (key20220330120639_b17-ETM-0-0-11186) 2018; 25
Shih (key20220330120639_b6-ETM-0-0-11186) 2010; 302
Poetschke (key20220330120639_b21-ETM-0-0-11186) 2016; 14
Scrimali (key20220330120639_b3-ETM-0-0-11186) 2010; 12
Ilie (key20220330120639_b2-ETM-0-0-11186) 2019; 18
Butzelaar (key20220330120639_b18-ETM-0-0-11186) 2015; 23
Huang (key20220330120639_b8-ETM-0-0-11186) 2013; 35
Fitzpatrick (key20220330120639_b13-ETM-0-0-11186) 1988; 124
Gozali (key20220330120639_b5-ETM-0-0-11186) 2015; 8
Shammas (key20220330120639_b10-ETM-0-0-11186) 2011; 14
Li-Tsang (key20220330120639_b4-ETM-0-0-11186) 2005; 31
Gauglitz (key20220330120639_b1-ETM-0-0-11186) 2011; 17
Kiprono (key20220330120639_b16-ETM-0-0-11186) 2015; 173
Zhu (key20220330120639_b11-ETM-0-0-11186) 2014; 9
Glass (key20220330120639_b7-ETM-0-0-11186) 2017; 18 (Suppl)
Idriss (key20220330120639_b14-ETM-0-0-11186) 2009; 15
Wu (key20220330120639_b9-ETM-0-0-11186) 2004; 57
References_xml – volume: 35
  start-page: 421
  year: 2012
  ident: key20220330120639_b20-ETM-0-0-11186
  article-title: Smoking and its effect on scar healing
  publication-title: Eur J Plast Surg
  doi: 10.1007/s00238-011-0661-3
  contributor:
    fullname: Deliaert
– volume: 12
  start-page: 218
  year: 2010
  ident: key20220330120639_b3-ETM-0-0-11186
  article-title: Treatment of hypertrophic scars and keloids with a fractional CO2 laser: A personal experience
  publication-title: J Cosmet Laser Ther
  doi: 10.3109/14764172.2010.514924
  contributor:
    fullname: Scrimali
– volume: 15
  start-page: 1
  year: 2009
  ident: key20220330120639_b14-ETM-0-0-11186
  article-title: Scar assessment scales: A dermatologic overview
  publication-title: Ski Res Technol
  doi: 10.1111/j.1600-0846.2008.00327.x
  contributor:
    fullname: Idriss
– volume: 17
  start-page: 113
  year: 2011
  ident: key20220330120639_b1-ETM-0-0-11186
  article-title: Hypertrophic scarring and keloids: Pathomechanisms and current and emerging treatment strategies
  publication-title: Mol Med
  doi: 10.2119/molmed.2009.00153
  contributor:
    fullname: Gauglitz
– volume: 14
  start-page: 467
  year: 2016
  ident: key20220330120639_b21-ETM-0-0-11186
  article-title: Aktuelle optionen zur behandlung pathologischer Narben
  publication-title: J Dtsch Dermatol Ges
  doi: 10.1111/ddg.13027_g
  contributor:
    fullname: Poetschke
– volume: 23
  start-page: 531
  year: 2015
  ident: key20220330120639_b18-ETM-0-0-11186
  article-title: Going into surgery: Risk factors for hypertrophic scarring
  publication-title: Wound Repair Regen
  doi: 10.1111/wrr.12302
  contributor:
    fullname: Butzelaar
– volume: 302
  start-page: 319
  year: 2010
  ident: key20220330120639_b6-ETM-0-0-11186
  article-title: Genetics of keloid scarring
  publication-title: Arch Dermatol Res
  doi: 10.1007/s00403-009-1014-y
  contributor:
    fullname: Shih
– volume: 173
  start-page: 852
  year: 2015
  ident: key20220330120639_b16-ETM-0-0-11186
  article-title: Epidemiology of keloids in normally pigmented Africans and African people with albinism: Population-based cross-sectional survey
  publication-title: Br J Dermatol
  doi: 10.1111/bjd.13826
  contributor:
    fullname: Kiprono
– volume: 57
  start-page: 1276
  year: 2004
  ident: key20220330120639_b9-ETM-0-0-11186
  article-title: Gene expression of early hypertrophic scar tissue screened by means of cDNA microarrays
  publication-title: J Trauma
  doi: 10.1097/01.ta.0000108997.49513.dc
  contributor:
    fullname: Wu
– volume: 18 (Suppl)
  start-page: S50
  year: 2017
  ident: key20220330120639_b7-ETM-0-0-11186
  article-title: Current understanding of the genetic causes of keloid formation
  publication-title: J Investig Dermatology Symp Proc
  doi: 10.1016/j.jisp.2016.10.024
  contributor:
    fullname: Glass
– volume: 69
  start-page: 163
  year: 2016
  ident: key20220330120639_b19-ETM-0-0-11186
  article-title: Currently known risk factors for hypertrophic skin scarring: A review
  publication-title: J Plast Reconstr Aesthetic Surg
  doi: 10.1016/j.bjps.2015.11.015
  contributor:
    fullname: Butzelaar
– volume: 18
  start-page: 916
  year: 2019
  ident: key20220330120639_b2-ETM-0-0-11186
  article-title: Capsaicin: Physicochemical properties, cutaneous reactions and potential applications in painful and inflammatory conditions (Review)
  publication-title: Exp Ther Med
  doi: 10.3892/etm.2019.7513
  contributor:
    fullname: Ilie
– volume: 10
  issue: 110
  year: 2009
  ident: key20220330120639_b12-ETM-0-0-11186
  article-title: Telomere shortening may be associated with human keloids
  publication-title: BMC Med Genet
  doi: 10.1186/1471-2350-10-110
  contributor:
    fullname: De Felice
– volume: 8
  start-page: 33
  year: 2015
  ident: key20220330120639_b5-ETM-0-0-11186
  article-title: Effective treatments of atrophic acne scars
  publication-title: J Clin Aesthet Dermatol
  contributor:
    fullname: Gozali
– volume: 35
  start-page: 64
  year: 2013
  ident: key20220330120639_b8-ETM-0-0-11186
  article-title: A snapshot of gene expression signatures generated using microarray datasets associated with excessive scarring
  publication-title: Am J Dermatopathol
  doi: 10.1097/DAD.0b013e31825ba13f
  contributor:
    fullname: Huang
– volume: 14
  start-page: 28
  year: 2011
  ident: key20220330120639_b10-ETM-0-0-11186
  article-title: Telomeres, lifestyle, cancer, and aging
  publication-title: Curr Opin Clin Nutr Metab Care
  doi: 10.1097/MCO.0b013e32834121b1
  contributor:
    fullname: Shammas
– volume: 25
  issue: 22
  year: 2018
  ident: key20220330120639_b17-ETM-0-0-11186
  article-title: Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: Clinical impacts in cancer
  publication-title: J Biomed Sci
  doi: 10.1186/s12929-018-0422-8
  contributor:
    fullname: Leão
– volume: 124
  start-page: 869
  year: 1988
  ident: key20220330120639_b13-ETM-0-0-11186
  article-title: The validity and practicality of sun-reactive skin types I through VI
  publication-title: Arch Dermatol
  doi: 10.1001/archderm.124.6.869
  contributor:
    fullname: Fitzpatrick
– volume: 9
  issue: e97114
  year: 2014
  ident: key20220330120639_b11-ETM-0-0-11186
  article-title: MicroRNA-21 regulates hTERT via PTEN in hypertrophic scar fibroblasts
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0097114
  contributor:
    fullname: Zhu
– volume: 31
  start-page: 610
  year: 2005
  ident: key20220330120639_b4-ETM-0-0-11186
  article-title: Prevalence of hypertrophic scar formation and its characteristics among the Chinese population
  publication-title: Burns
  doi: 10.1016/j.burns.2005.01.022
  contributor:
    fullname: Li-Tsang
– volume: 345
  start-page: 93
  year: 2016
  ident: key20220330120639_b15-ETM-0-0-11186
  article-title: Fibroproliferative effect of microRNA-21 in hypertrophic scar derived fibroblasts
  publication-title: Exp Cell Res
  doi: 10.1016/j.yexcr.2016.05.013
  contributor:
    fullname: Li
SSID ssj0000561885
Score 2.288998
Snippet Hypertrophic and atrophic scars are the effect of a dysregulated wound-healing process in genetically predisposed individuals. The genetic predisposition has...
SourceID pubmedcentral
proquest
gale
crossref
SourceType Open Access Repository
Aggregation Database
SubjectTerms Cicatrices
Comparative analysis
Development and progression
Family medical history
Fibroblasts
Genetic aspects
Genotype & phenotype
Health aspects
Inflammation
Overweight
Patients
Physiology
Risk factors
Scars
Single nucleotide polymorphisms
Software
Telomerase
White people
Wound healing
Title Role of hTERT rs2736100 in pathological scarring
URI https://www.proquest.com/docview/2644760062
https://pubmed.ncbi.nlm.nih.gov/PMC8892623
Volume 23
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ07b8IwEICtwtSl6lOlpZWHii4EjGPAGREFsbRCLZW6WbaJBRIERGDg3_cuj0IYO8dR7PPZd-ecvyPkBeNp7XzjBb41HvJKPG1M4PGQhYFxMnTJgf7oq_vxI98GiMlp53dhkqR9a-aNaLFsRPNZklu5XtpmnifWHL_3pUTKnd8skRL4hkchegr07rRkUooTdI17LJCtFNYIppk3wy1eP-cctwqJ9YsQBwoRWadgl05359OMySMTNLwkF5nvSHtpH6_IWRhdk9o4hU_v63RyuEsV12mNjg9Y6v0NYZ-rRUhXjs7Ag53QTQwuBXg1jM4jinWJ812QxlZv8LTvlnwPB5P-yMvqJXgWzPDWc1oIjYRBaXjgOJNTMEtgb_x2AGO3YMinXKJNNj73DTNsagXS2VvWWVjYgX9HytEqCu8JFeBFaSORDqZFV8DuLALBdMsx7bs2ExXymktLrVMshoJwAkWsQMQKRawSEUNLFKbC9QKiszpL-4fvIHlK9bqIfcIwqUKqhZag57b4OJ8Ola2zWKE7h78WO7xCuoUp-usW8rOLT0CtEo52pkYP_37zkZzjQNNEniopbze78ImU4unuOdHJX1GQ4ZA
link.rule.ids 230,315,729,782,786,887,27933,27934,53800,53802
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xHODCjiirDwguhLqO2zpHVIqKWFRBkbhZthuLSjStmnLg75nJAoQjZzuK4-fZnJk3AKcUTxsf2iAKnQ2IryQw1kaBiHkcWa9in13o957bj6_quks0Oc2yFiZL2nd2dJm8jy-T0VuWWzkdu3qZJ1bvP3SUIpa7sL4IyyivnP8K0nNK71ZDZc048bSJgEeqkdM1onEW9XhOBehCkLJQ1MGICEExJmtVLNNf_fw3Z_KXEbpZ_-fyN2Ct8DrZVT68CQtxsgVn_Zy2-vOCDX6qsNILdsb6P4TWn9vAnybvMZt49oa-74DNUnRG0B_ibJQw6mhc6k-WOjOje8IdeLnpDjq9oOi0EDg04PPAGykNcRMqKyIvuBqiQUNLFTYj3DOHLsBQKLLmNhSh5ZYPnSRe94bzDlVCFO7CUjJJ4j1gEv0vYxXxihnZlqjXZSS5aXhuQt_ksgbn5S7raU6ooTEQIWg0QqMJGp1BgzMJBE2ShlvuTFEwgO8hzip91SbCKAqwanBYmYkS4qrDJYy6kNBUkyNIPyVbogbtCrTfyyLm7eoIIpoxcBcI7v_7yRNY6Q0e7vX97ePdAazSR-fpQIewNJ99xEewmA4_jrNz_QXLhvce
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpZ3JTsMwEIZHLBLiwo4oqw8ILoS4jmmdIwIqEIsqKBI3y3ZitRKkVVMOvD0zSQqEI5zjKIn_eJZk_A3AIeXTxkc2iCNnA-KVBMbaOBApT2PrVeqLD_rXT-2HF3V5RZicr1ZfRdG-s4PT7PXtNBv0i9rK0ZsLp3ViYff-Qimi3EXhKPHhLMzjmuXiR6JeYr1bTVU05MQ3TgQ8Vs0S2YgOWoTphDahC0EGQ1EXI4KCYl7Wqnmn3zb6d93kD0fUWf7HI6zAUhV9svNyyCrMpNkaHHVLfPXHCet978bKT9gR636DrT_WgT8OX1M29KyPMXCPjXMMSjAu4myQMepsPLWjLHdmTN8LN-C5c9W7uA6qjguBQ0c-CbyR0hCjUFkRe8FVgo4NPVZ0FuO8OQwFEqHIq9tIRJZbnjhJfPem8w5NQxxtwlw2zNItYBLjMGMV8cWMbEu07zKW3DQ9N5E_47IBx9OZ1qMSrKExISF5NMqjSR5dyIMjSQhNKw6n3Zlq4wBeh9hV-rxN4ChKtBqwWxuJK8XVD0-l1NVKzTUFhPRzsiUa0K7J-3VbROCuH0FVCxJ3peL2n888gIXuZUff3Tzc7sAiPXNZFbQLc5Pxe7oHs3nyvl-82p_Jzfme
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Role+of+hTERT+rs2736100+in+pathological+scarring&rft.jtitle=Experimental+and+therapeutic+medicine&rft.au=Halmagyi%2C+Salomea-Ruth&rft.au=C%C4%83tan%C4%83%2C+Andreea&rft.au=Aioanei%2C+Casian+Simon&rft.au=Lukacs%2C+Istvan&rft.date=2022-04-01&rft.pub=Spandidos+Publications+UK+Ltd&rft.issn=1792-0981&rft.eissn=1792-1015&rft.volume=23&rft.issue=4&rft_id=info:doi/10.3892%2Fetm.2022.11186&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1792-0981&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1792-0981&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1792-0981&client=summon